戻る Agenda
SESSION 9: Bringing Innovation to the MEA Region
Session Chair(s)
Dina Fathy, MPharm, AHIP
Senior Director, Regulatory Affairs Middle East Subregional Lead
MSD UAE, United Arab Emirates
Abdulrahim Alyahya
SaudiArabia Regulatory WG; Director-Regulatory Policy, Governmental Affair & TSO
Biogen, Saudi Arabia
Overview: In this Session, we will identify and highlight different tools and initiatives across the Middle and North Africa to bring innovation to the Region, including Pharma Industry advances, IP, groundbreaking research, advanced technologies, and transformative regulatory pathways. That all ensures continuous commitment to innovation, to drive scientific and economic value, to evolve the regional healthcare systems, and faster patient access to innovative medications. Furthermore, we will dive into different tools and new pathways that help attract and bring innovation to the region, and what we could do more or differently to keep focusing on innovation.
Speaker(s)
The IP Ecosystem in GCC: Building confidence for Innovation and Access
Ahmad Saleh
Tamimi & Co., United Arab Emirates
Partner, Head of Innovation, Patents, Industrial Property, & AI
Accelerating Access for Innovation: The SFDA experience
Ahmad Al Menea
Saudi Food and Drug Authority (SFDA), Saudi Arabia
Head - Pharmaceutical Products Registration Section (Drug Sector)
EDA Regulatory Perspectives for Innovative Medicinal Products
Sara Shatat
Egyptian Drug Authority (EDA), Egypt
Head - General Administration of Innovative Products
Panel Discussion with Q&A (With the additional participation of):
Panellist(s) Invited
Qatar